MedPath

Amakem NV

Amakem NV logo
๐Ÿ‡ง๐Ÿ‡ชBelgium
Ownership
Private
Established
2010-01-01
Employees
11
Market Cap
-
Website
http://www.amakem.com

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
Ocular Hypertension
Eye Disease
Glaucoma
Interventions
Drug: Placebo
First Posted Date
2014-05-13
Last Posted Date
2015-01-21
Lead Sponsor
Amakem, NV
Target Recruit Count
103
Registration Number
NCT02136940
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Artesia Clinical - Site 11, Artesia, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Inglewood Clinical Site - Site 15, Inglewood, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Petaluma Clinical Site - Site 17, Petaluma, California, United States

and more 6 locations

A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects

Phase 1
Completed
Conditions
Glaucoma
Ocular Hypertension
Eye Disease
Interventions
Drug: Placebo
First Posted Date
2013-12-06
Last Posted Date
2014-05-02
Lead Sponsor
Amakem, NV
Target Recruit Count
21
Registration Number
NCT02003547

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Phase 2
Completed
Conditions
Glaucoma
Ocular Hypertension
Eye Disease
Interventions
Drug: Placebo
First Posted Date
2012-09-26
Last Posted Date
2013-07-17
Lead Sponsor
Amakem, NV
Target Recruit Count
82
Registration Number
NCT01693315
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Artesia Clinical Site - Site 02, Artesia, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Inglewood Clinical Site - Site 03, Inglewood, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Petaluma Clinical Site - Site 05, Petaluma, California, United States

and more 3 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath